BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3293936)

  • 1. Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Beta-lactam antibiotics.
    Lietman PS
    Chest; 1988 Aug; 94(2 Suppl):115S-120S. PubMed ID: 3293936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic therapy of pulmonary infections in cystic fibrosis. Dosage schedules and duration of treatment.
    Strandvik B
    Chest; 1988 Aug; 94(2 Suppl):146S-149S. PubMed ID: 3396437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Chest; 1988 Aug; 94(2 Suppl):97S-169S. PubMed ID: 3396440
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of antibiotics in cystic fibrosis patients with particular reference to the bronchopulmonary tree (review).
    Bergogne-Berezin E
    Infection; 1987; 15(4):288-94. PubMed ID: 3312023
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.
    Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA
    Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
    Levy J
    Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.
    Michel BC
    Chest; 1988 Aug; 94(2 Suppl):129S-140S. PubMed ID: 3293939
    [No Abstract]   [Full Text] [Related]  

  • 8. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment. Aerosol therapy.
    Hodson ME
    Chest; 1988 Aug; 94(2 Suppl):156S-162S. PubMed ID: 3396438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial therapy against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia.
    Geddes DM
    Chest; 1988 Aug; 94(2 Suppl):140S-145S. PubMed ID: 3293940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotics in the treatment of cystic fibrosis].
    Stoppelman MR
    Maandschr Kindergeneeskd; 1969 Oct; 37(4):113-9. PubMed ID: 5345411
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review.
    Castagnola E; Cangemi G; Mesini A; Castellani C; Martelli A; Cattaneo D; Mattioli F
    Int J Antimicrob Agents; 2021 Sep; 58(3):106381. PubMed ID: 34157401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious Diseases Pharmacotherapy for Children With Cystic Fibrosis.
    Molloy L; Nichols K
    J Pediatr Health Care; 2015; 29(6):565-78; quiz 579-80. PubMed ID: 26498903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimising β -lactam Dosing in Neonates: A Review of Pharmacokinetics, Drug Exposure and Pathogens.
    Fuchs A; Li G; van den Anker JN; Bielicki J
    Curr Pharm Des; 2017; 23(38):5805-5838. PubMed ID: 28950814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis.
    Stutman HR; Shalit I; Marks MI; Greenwood R; Chartrand SA; Hilman BC
    Am J Med; 1987 Apr; 82(4A):142-5. PubMed ID: 3555028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations.
    Lindsay CA; Bosso JA
    Clin Pharmacokinet; 1993 Jun; 24(6):496-506. PubMed ID: 8513651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home treatment of pulmonary infection in cystic fibrosis.
    Kuzemko JA
    Chest; 1988 Aug; 94(2 Suppl):162S-166S. PubMed ID: 3396439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections.
    Drusano GL; Craig WA
    J Chemother; 1997 May; 9 Suppl 3():38-44. PubMed ID: 9248979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
    Nichols L; Maki DG
    Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early lung disease in cystic fibrosis.
    Grasemann H; Ratjen F
    Lancet Respir Med; 2013 Apr; 1(2):148-57. PubMed ID: 24429095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.